Studies of some mechanisms of drug resistance in chronic myeloid leukemia (CML)

Advances in Experimental Medicine and Biology

Volumn 457, Issue , 1999, Pages 477-488

  Turkina, Anna G ^a   Logacheva, Natalia P ^b   Stromskaya, Tatjana P ^b   Zabotina, Tatjana N ^a   Kuznetzov, Sergei V ^a   Sachibzadaeva, Kuralay K ^a   Tagiev, Akshin ^a   Juravlev, Vacheslav S ^a   Khoroshko, Nina D ^a   Baryshnikov, Anatoly Y ^b   Stavrovskaya, Alla A ^b  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Apoptosis; BCR ABL translocation variants; CML; Drug resistance; P glycoprotein

Indexed keywords

BCR ABL PROTEIN; FAS ANTIGEN; GLYCOPROTEIN P;

APOPTOSIS; ARTICLE; CHROMOSOME 22; CHROMOSOME 9; CHRONIC MYELOID LEUKEMIA; FEMALE; GENE; GENE TRANSLOCATION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; MORTALITY; MULTIDRUG RESISTANCE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ANTIGENS, CD95; APOPTOSIS; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; DRUG RESISTANCE, MULTIPLE; FEMALE; FUSION PROTEINS, BCR-ABL; GENES, MDR; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; P-GLYCOPROTEIN; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TRANSLOCATION, GENETIC;

EID: 0032605676     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4811-9_52     Document Type: Article

References (19)

1. Konopka, J.B., Watanabe, S.M., Witte, O.N. An alteration of the human ABL protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell, 1984, 37, 1035-1043.
2. Kloetzer,W., Kurzrock, R., Smith, I., Talpaz, M., Spiller, M., Gutterman, I., Arlinghaus, R. The human cellular ABL gene product in chronic myelogeneous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology, 1985, 140, 230-238.
3. Jones, R.J. Biology and treatment of chronic myeloid leukemia. Current Opinion in Oncology, 1997, 9, 3-7.
4. Bedi, A., Zehnbauer, B.A., Barber, J.P., Sharkis, S.J., Jones, R.J. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 1994, 83, 2038- 2044.
5. Mc Gahon, A., Bissonnette, R., Schmitt, M., Cotter, K.M., Green, D.R., Cotter, T.G. BCR-ABL maintains resistance of chronic myeloid leukemia cells to apoptotic death. Blood, 1994, 83, 1179-1187.
6. Gordon, M.Y., Goldman, J.M. Cellular and molecular mechanisms in chronic myeloid leukemia: biology and treatment. Br. J. Haemat. 1996, 95, 10-20.
7. Bedi, A., Barber, J.P., Bedi, G.C., El-Deiry, W.S., Sidransky, D., Vala, M.S., Akhtar, A.J., Hilton, J., Jones, R.J. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition following DNA damage: a mechanism of resistance to multiple anticancer agents. Blood, 1995, 86, 1148-1158.
8. Roger, R., Issaad, C., Pallardy, M., Turhan, A.Gg, Beroglio, J., Breard, J. BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells. Blood, 1996, 87, 1113-1122.
9. Mechetner, E.B., Roninson, I.B. Efficient inhibition of P-glycoprotein -mediated multidrug resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. USA, 1992, 89, 5824-5828.
10. Schinkel, A.H., Arceci, R.J., Smith, J.J.M., Wagenaar, E., Baas, R, Doll, M., Tsuruo, T., Mechetner, E.B., Roninson, I.B., Borst, P. Binding properties of monoclonal antibodies recognazing external epitopes of the human MDR1 P-glycoprotein. Int.J.Cancer, 1993, 55, 478-484.
11. Frolova, E. A., Baryshnikov, A.Yu., Moiseenkova, I.N., Tupitsin, N.N., Turkina A.G. Heterogeneity in immunological types of chronic myeloid blast crisis. Haematologia i Transfusiologia, 1992, 5, 6-11 (in Russian).
12. Neyfakh, A.A. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res., 1988, 174, 168-176.
13. Egudina S.V., Stromskaya, T.P., Frolova E.A., Stavrovskaya, A.A. Early steps of P-glycoprotein expression in cell cultures studied with vital fluorochrome. FEBS Letters, 1993, 329, 63-66.
14. Melo, J.V. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood, 1996, 88, 2375-2784.
15. Weide, R., Dowding, C., Paulsen, W., Goldman, J. The role of MDR-1/P-170 mechanism in development of multidrug resistance in chronic myeloid leukemia. Leukemia, 1990, 4, 695-699.
16. Michelutti, A., Michieli, M., Damiani., D., Melli, C., Geromin, A., Russo, D., Fanin, R., Baccarani, M. Overexpression of MDR-related P-170 glycoprotein in chronic myeloid leukemia. Haematologica, 1994, 79, 200-204.
17. Baryshnikov, A.Ju., Turkina A.G., Michailova, I.N., Sedyakhina, N.P., Shishkin, Ju.V., Korolyova, A.M., Palkina, T.N., Ivanov, P.K., Frolova, E.A., Mokeyeva, R.A., Khoroshko, N.D. In: Gene Technology. Stem Cell and Leukemia Research, 1996, Edited by A.R.Zander, W.Ostertag, B.V.Afanasiev, F.Grosveld, NATO ASI Series, Series H: Cell biology,vol. 94, 475-484. Springer-Verlag Berlin Heidelberg.
18. Turkina, A.G., Domninsky, D.A., Pokrovskaya, E.S., Babushkina, E.A., Moiseenkova, I.N., Zacharova, A.V., Archipova, N.V., Grineva, N.I., Khorochko, N.D. Prognostic value of the structure of the variants of chromosome translocation t(9;22) in chronic myeloid leukemia. Gematologia, 199 , 3, 8-11 (in Russian).
19. McGahon, A.J., Nishioka, W.K., Martin, S.J., Mahboubi, A., Cotter, T.G., Green, D.R. Regulation of the Fas apoptotic cell death patway by Abl. J.Biol.Chem., 1995, 270, 22625-22631.